Topically applied CUTIVATE® Lotion can be absorbed in sufficient amounts to produce systemic effects (see PRECAUTIONS).
CUTIVATE® Lotion may be used in adult and pediatric patients 1 year of age or older. The safety and efficacy of CUTIVATE® Lotion in pediatric patients below 1 year of age have not been established (see PRECAUTIONS: Pediatric Use).
Atopic Dermatitis: Apply a thin film of CUTIVATE® Lotion to the affected skin areas once daily. Rub in gently.
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. The safety and efficacy of drug use for longer than 4 weeks have not been established.
CUTIVATE® Lotion should not be used with occlusive dressings or applied in the diaper area unless directed by a physician.
CUTIVATE® Lotion is supplied in
60 mL bottle NDC 0462-0434-60
120 mL bottle NDC 0462-0434-04
Store between 15° and 30°C (59° and 86°F). Do not refrigerate.
Keep container tightly sealed.
A division of Nycomed US Inc.
Melville, NY 11747 USA
Patent No. 7300669
For Topical Use Only –
Not for ophthalmic, oral
or intravaginal use.
Rx only 120 mL
| CUTIVATE |
fluticasone propionate lotion
|Labeler — PharmaDerm, A division of Nycomed US Inc. (043838424)|
|Nycomed US Inc.||043838424||ANALYSIS|
|Nycomed US Inc.||174491316||MANUFACTURE|
Revised: 05/2011 PharmaDerm, A division of Nycomed US Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.